Comment: Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
We write to express our concerns on the adoption of only physician-rated outcome measurement, namely the Psoriasis Area and Severity Index, in this otherwise exceptionally well conducted randomised controlled trial, without the adoption of any patient-rated outcome variable, such as quality of life...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Our Dermatology Online
2014-04-01
|
| Series: | Nasza Dermatologia Online |
| Subjects: | |
| Online Access: | http://www.odermatol.com/issue-in-html/2014-2-3a-comment/ |